Spearheaded investments in founder-led / family-owned companies with $5M to $50M in EBITDA, primarily in the consumer space, for Cathay Capital, a private equity firm with $5b+ under management.Actively worked with portfolio companies to develop and execute value creation plans, identifying key operational improvements and growth initiatives, leading to significant EBITDA growth and successful exits, through:- Fueling organic growth, including but not limited to channels and geographies expansion, product extensions and new business launches,- Operational excellence,- Developing organizational capabilities through the recruitment of C-suite executives,- Developing strong relationships with portfolio company CEOs and management teams, providing mentorship and strategic guidance to achieve business objectives,- Capturing digital transformation opportunities, - Pursuing strategic acquisitions, - Optimizing capital structure, including raising debt and equity to fund growth, and- Providing hands-on support to portfolio companies during critical transitions, including turnarounds, mergers, and acquisitions.

Sourced, structured, negotiated and executed private equity investments in the US for the $600m Prudential-Fosun Fund managed by Fosun International, one of the largest investment groups in China.

Originated, structured, executed and monitored investments between Europe and China for Cathay Capital, a private equity firm with $5b+ under management.

Patrick CHOAY Group is a pharmaceutical group comprising 5 companies: Laboratoire CCD, Laboratoire Bailly Creat, Laboratoire Goménol, CCD Bioes Santé and Prodimed.

Advised Fortune 500 clients on strategic and operational issues, using qualitative and quantitative analytical tools. Projects for global clients in the Pet Food, Consumer Eye Care and Telco/ISP industries.

Consultant for the East Asia Transport Division